Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)].
Gligorov J, Bachelot T, Pierga JY, Antoine EC, Balleyguier C, Barranger E, Belkacemi Y, Bonnefoi H, Bidard FC, Ceugnart L, Classe JM, Cottu P, Coutant C, Cutuli B, Dalenc F, Darai E, Dieras V, Dohollou N, Giacchetti S, Goncalves A, Hardy-Bessard AC, Houvenaeghel G, Jacquin JP, Jacot W, Levy C, Mathelin C, Nisand I, Petit T, Petit T, Poncelet E, Rivera S, Rouzier R, Salmon R, Scotté F, Spano JP, Uzan C, Zelek L, Spielmann M, Penault-Llorca F, Namer M, Delaloge S. Gligorov J, et al. Among authors: ceugnart l. Bull Cancer. 2020 May;107(5):528-537. doi: 10.1016/j.bulcan.2020.03.008. Epub 2020 Apr 1. Bull Cancer. 2020. PMID: 32278467 Free PMC article. French. No abstract available.
Is there a reliable method to assess the complete pathologic response on the tumor after neo-adjuvant chemotherapy in inflammatory breast cancer toward recommendations for the pathologic process? Experience in 56 patients treated in a single institution.
Mailliez A, Baranzelli MC, Giard S, Ceugnart L, Vanlemmens L, Belkacemi Y, Robin YM, Bonneterre J. Mailliez A, et al. Among authors: ceugnart l. Breast J. 2010 Sep-Oct;16(5):464-71. doi: 10.1111/j.1524-4741.2010.00957.x. Epub 2010 Aug 16. Breast J. 2010. PMID: 20722651
[Endometrial cancer imaging].
Taïeb S, Rocourt N, Narducci F, Ceugnart L. Taïeb S, et al. Among authors: ceugnart l. Bull Cancer. 2012 Jan;99(1):13-20. doi: 10.1684/bdc.2011.1500. Bull Cancer. 2012. PMID: 22134048 Free article. Review. French.
[Ductal carcinoma in situ diagnosis: 3 French national guidelines].
Cutuli B, Tunon De Lara C, Arnaud A, Bertheau P, Boulanger L, Boute V, Ceugnart L, Chauvet MP, Coutant C, De Cremoux P, Fourquet A, Hennequin C, Lesieur A, Lesur A, Lévy L, Vincent-Salomon A, Besnard S, Belorgey C. Cutuli B, et al. Among authors: ceugnart l. Ann Pathol. 2016 Jun;36(3):166-73. doi: 10.1016/j.annpat.2016.03.012. Epub 2016 May 25. Ann Pathol. 2016. PMID: 27236350 French.
Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS.
Balleyguier C, Dunant A, Ceugnart L, Kandel M, Chauvet MP, Chérel P, Mazouni C, Henrot P, Rauch P, Chopier J, Zilberman S, Doutriaux-Dumoulin I, Jaffre I, Jalaguier A, Houvenaeghel G, Guérin N, Callonnec F, Chapellier C, Raoust I, Mathieu MC, Rimareix F, Bonastre J, Garbay JR. Balleyguier C, et al. Among authors: ceugnart l. J Clin Oncol. 2019 Apr 10;37(11):885-892. doi: 10.1200/JCO.18.00595. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811290 Clinical Trial.
[French program of breast cancer screening: Radiologist viewpoint].
Ceugnart L, Rocourt N, Ben Haj-Amor M, Bachelle F, Boulanger T, Chaveron C, Pouliquen G, Renaud A, Taieb S. Ceugnart L, et al. Bull Cancer. 2019 Jul-Aug;106(7-8):684-692. doi: 10.1016/j.bulcan.2019.03.003. Epub 2019 Apr 30. Bull Cancer. 2019. PMID: 31047637 French.
[Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies].
Ceugnart L, Delaloge S, Balleyguier C, Deghaye M, Veron L, Kaufmanis A, Mailliez A, Poncelet E, Lenczner G, Verzaux L, Gligorov J, Thomassin-Naggara I. Ceugnart L, et al. Bull Cancer. 2020 Jun;107(6):623-628. doi: 10.1016/j.bulcan.2020.04.006. Epub 2020 May 7. Bull Cancer. 2020. PMID: 32416925 Free PMC article. French. No abstract available.
[Second reading in breast cancer screening program: State of knowledge and future].
Ceugnart L, Doutriaux-Dumoulin I, Heid P, Orabona J, Deghaye M, Dufour M, Tardivon A, Potocki J, Gautier CP, Brault I, Rymzhanova R, Barraux-Krabe M, Seradour B. Ceugnart L, et al. Bull Cancer. 2022 Jul-Aug;109(7-8):768-779. doi: 10.1016/j.bulcan.2022.03.004. Epub 2022 May 20. Bull Cancer. 2022. PMID: 35599171 Review. French.
[Digitalization of the French breast cancer screening program].
Deghaye M, Tardivon A, Heid P, Quertier MC, Soler-Michel P, Dufour M, Hoarau R, Rymzhanova R, Daigneau S, Dehaene JL, Ceugnart L. Deghaye M, et al. Among authors: ceugnart l. Bull Cancer. 2022 Jul-Aug;109(7-8):760-767. doi: 10.1016/j.bulcan.2022.02.019. Epub 2022 May 24. Bull Cancer. 2022. PMID: 35624044 French. No abstract available.
62 results